The Journal of Immunology · 2014 · 18 citations · 27 references
Life SciencesImmunologyMolecular BiologyCellular ImmunologyImmunopathologyMolecular ImmunologyAntigen PresentationAntigen RecognitionCell-mediated ImmunityHuman Leukocyte Antigen SystemMajor Histocompatibility ComplexT Cell ActivationCd8 Positive T CellsCd8 T Cell ActivationCell ActivationHla Class I MoleculesImmunological MechanismsMhc Class I MoleculesMhc-peptide RecognitionNonclassical Hla Molecules
Accumulating evidence that serum levels of soluble class I HLA molecules (sHLA-I) can, under various pathological conditions, correlate with disease stage and/or patient survival, has stimulated interest in defining whether sHLA-I can exert immunological functions. However, despite a mounting number of publications suggesting the ability of sHLA-I to affect immune effectors in vitro, the precise underlying mechanism still remains controversial. In this article, we address potential functions of both classical and nonclassical sHLA-I, using soluble recombinant HLA-I/peptide monomers, and clearly demonstrate their ability to trigger Ag-specific activation of CD8 T cells in vitro. Furthermore, we provide strong evidence that this behavior results from the passive transfer of peptides from monomers to T cell-bound HLA-I molecules, allowing for fratricide representation and activation. Hence, we proposed a unifying model of T cell activation by HLA-I/peptide monomers, reappraising the potential involvement of sHLA-I molecules in the immune response.
27
Evidence that a Single Peptide–MHC Complex on a Target Cell Can Elicit a Cytolytic T Cell Response
Yuri Sykulev, Michael Joo, Irina Vturina et al. · Immunity · 1996 · 706 citations · Full text
David N. Garboczi, Deborah T. Hung, Don C. Wiley · Proceedings of the National Academy of Sciences · 1992 · 701 citations